doi: 10.1007/BF01314739.
In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate
- PMID: 6449917
- DOI: 10.1007/BF01314739
Item in Clipboard
In vitro inhibition of Herpesvirus sylvilagus by phosphonoacetic acid and phosphonoformate
Arch Virol.
1980.
Abstract
Phosphonoacetic acid and phosphonoformate were examined as inhibitors of Herpesvirus sylvilagus replication in cultured cells. Both drugs produced significant inhibition at a minimum concentration of 25 micrograms per milliliter.
Similar articles
-
In vitro inhibition of human herpesvirus-6 by phosphonoformate.J Virol Methods. 1988 Sep;21(1-4):301-4. doi: 10.1016/0166-0934(88)90075-4. J Virol Methods. 1988. PMID: 2972736
-
Synergistic inhibition of anatid herpesvirus replication by acyclovir and phosphonocompounds.Intervirology. 1987;28(2):89-99. doi: 10.1159/000150000. Intervirology. 1987. PMID: 2965115
-
Comparison of the effect of trisodium phosphonoformate on the mean plaque size of pseudorabies virus, infectious bovine rhinotracheitis virus and pigeon herpesvirus.J Comp Pathol. 1980 Oct;90(4):625-33. doi: 10.1016/0021-9975(80)90111-5. J Comp Pathol. 1980. PMID: 6268670 No abstract available.
-
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).Pharmacol Ther. 1982;19(3):387-415. doi: 10.1016/0163-7258(82)90074-2. Pharmacol Ther. 1982. PMID: 6201932 Review. No abstract available.
-
The antiherpesvirus action of phosphonoacetate.Pharmacol Ther. 1979;4(1):231-43. doi: 10.1016/0163-7258(79)90021-4. Pharmacol Ther. 1979. PMID: 88744 Review. No abstract available.
Cited by
-
In vitro and in vivo inhibition of myxoma virus by treatment with phosphonoacetic acid.Arch Virol. 1981;70(2):157-64. doi: 10.1007/BF01315009. Arch Virol. 1981. PMID: 7332492